[Form 4] Vita Coco Company, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Martin Roper, listed as Director and Chief Executive Officer of Vita Coco Company, Inc. (COCO), reported sales of a total of 7,894 shares of common stock on 10/07/2025 under a Rule 10b5-1 trading plan at weighted average prices in the range of approximately $42.51–$42.91. After the transactions the filing reports 287,062 shares beneficially owned directly and 221,131 shares held indirectly through family trusts. The filing also discloses outstanding non-qualified stock options exercisable for 1,099,460 shares in aggregate, with several option grants fully vested and others vesting in scheduled installments through 2035. The sales were effected pursuant to a pre-established plan and the form was signed by an attorney-in-fact on behalf of the reporting person.
Positive
- None.
Negative
- None.
Insights
Insider executed Rule 10b5-1 sales and retains large option exposure.
The reporting person sold 7,894 shares on 10/07/2025 under a Rule 10b5-1 plan at weighted average prices roughly in the low $40s, reducing direct holdings to 287,062 shares while 221,131 shares remain indirectly held via family trusts. Using a 10b5-1 plan indicates the trades were pre-planned and intended to provide an affirmative defense to insider trading claims.
The reporting person also holds substantial stock option exposure totaling 1,099,460 underlying shares across multiple grants, including several fully vested options and others with vesting through 2035. This mix of sales and long-dated option holdings suggests partial liquidity-taking while remaining economically tied to future equity upside; monitor future 10b5-1 activity and option exercises within the next 12–24 months.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,835 | $42.745 | $78K |
| Sale | Common Stock | 2,275 | $42.83 | $97K |
| Sale | Common Stock | 1,384 | $42.75 | $59K |
| Sale | Common Stock | 2,400 | $42.773 | $103K |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.64 to $42.88, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.64 to $42.90, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are held by the Christopher G. Roper Exempt Family Trust. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.51 to $42.91, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are held by the Peter S. Roper Exempt Family Trust. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.51 to $42.90, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are held by the Thomas L. Roper Exempt Family Trust. The stock option is fully vested and currently exercisable. The stock option is fully vested and currently exercisable. The stock option vests in four equal annual installments beginning on November 27, 2022. The stock option vests in four equal annual installments beginning on March 10, 2024. The stock option vests in four equal annual installments beginning on March 4, 2025. The Stock Option vests in four equal annual installments beginning in March 3, 2026.
